The product portfolio
Five formulations.
One clear view of readiness.
Explore the purpose, delivery technology, evidence and next commercial milestone for each completed formulation.
Crops
EIR Biostimulant
Formula complete · field-tested · registration nextBotanical formulation for plant vitality and crop health.
How it works
A water-based botanical formulation combines plant-health chemistry with stable dispersion for agricultural application.
Evidence and readiness
- Completed
- Formulation complete; laboratory and crop trials; stability and emulsification testing.
- Next milestone
- Registration and marketing. The existing entry plan begins in Thailand, followed by ASEAN markets.
In a 29-day pepper greenhouse study, mean disease severity at 0.1% fell from 2.89 to 0.08. The final untreated-control score was 5.00.
Bangkok region; 250 m² in five zones. Disease severity was scored from 0 to 5. These are plant-health observations, not direct measurements of yield or nutrient-use efficiency.
Trial results and study conditions
Final disease severity on a scale from 0 (healthy) to 5 (full infection). The chart reports the formulation and conditions studied. Disease-severity findings are distinct from direct measurements of nutrient-use efficiency, abiotic-stress tolerance or yield.
Commercial application
A liquid application format and crop data provide a starting point for distributor-led positioning and market-specific claims.
Read the film transcript
Meet EIR. A nature-inspired biostimulant developed to support plant vitality and resilience. Its botanical formulation is designed to help crops maintain healthy growth and cope with stress, advancing a more sustainable approach to agriculture. Drawing on extensive experience, scientist Ido Eco Ofek developed a product that comes from nature to bring nature back to agriculture.
Crops
EIR PESTOX
Formula complete · field-tested · registration nextContact insecticide and acaricide with sustained formic acid release.
How it works
Phospholipids adhere to pests and interfere with sensing and feeding. Chemical equilibrium sustains formic acid release; cuticle damage promotes water loss and dehydration.
Evidence and readiness
- Completed
- Formulation complete; laboratory mortality observations, pepper aphid field trials, stability and emulsification testing.
- Next milestone
- Market-specific registration, approved labelling and distributor-led launch.
At three days after treatment, aphid control was 85.8% at 0.25% and 86.7% at 0.5%, compared with 29.2% for flonicamid at 0.015%.
Tzrufa, Israel, March 2022; pepper aphids; four replicates and three assessors. Observed means; inferential statistics were not supplied. These results relate to the tested pest and conditions.
Trial results and study conditions
4 replicates, 3 assessors. Observed means; inferential statistics were not provided. Lower-rate observations came from a separate site.
Commercial application
Combines contact action and sustained release. Commercial evaluation centres on target-pest control, treatment duration and application cost.
Read the film transcript
EIR PESTOX protects crops from insects and mites. Developed by scientist Eco Ofek, its phospholipids adhere to pests, disrupting sensing and feeding. Chemical equilibrium sustains formic acid release, damaging the cuticle and accelerating dehydration. Laboratory tests show rapid mortality. Natural origin ingredients. Prolonged contact action. Biodegradable by design. Apply outside bee activity to limit exposure. EIR PESTOX. Precision in formulation. Care for every harvest.
EIR PESTOX · completed formulation. Market-specific labels and commercial packaging will follow the registration requirements.
Poultry & livestock housing
EIROLITTER
Formula complete · field-tested · registration nextSustained litter acidification for ammonia management.
How it works
A mineral-supported acidity reserve becomes available progressively as litter moisture and alkalinity change through the production cycle.
Evidence and readiness
- Completed
- Formulation complete; stability testing, laboratory work and a successful commercial poultry comparison.
- Next milestone
- Market-specific registration, production and distribution planning, and marketing.
The treated house recorded 1–5 ppm ammonia across the cycle; the control reached 44.2 ppm at week six. Day-42 body weight was 2,798 g versus 2,446 g (+14.4%).
Galilee, Israel, December 2025–January 2026; two houses of 25,000 Ross 308 broilers, one house per treatment. Both outcomes come from the same comparison; house-level differences limit causal attribution.
Trial results and study conditions
Commercial application
Addresses continuing ammonia pressure through the growing cycle. Buyers can assess cost per house or flock alongside measured housing conditions.
Laying hens
EIR AVIBIOME
Formula complete · lab-tested · field trials nextProtected feed ingredients for intestinal function, microbial balance and eggshell support.
How it works
A homogeneous lipid-matrix flake combines protected butyrate and monolaurin with calcium, vitamin D3 and boron citrate, designed for feed handling and intestinal delivery.
Evidence and readiness
- Completed
- Formulation complete; laboratory-tested. The public summary does not report assay-level methods or quantitative laboratory results.
- Next milestone
- Controlled laying-hen field trials; measurement of delivery, tolerance and biological outcomes before market-entry claims are finalised.
The completed formulation has a laboratory foundation. Animal performance and eggshell benefits are intended outcomes awaiting controlled animal field trials.
Detailed laboratory methods and results require dossier review. Ingredient literature supports the rationale but is not a substitute for product-specific animal results.
Commercial application
Brings gut-directed ingredients and an eggshell-support module into one flake. Trial priorities connect delivery with outcomes and cost per tonne of feed.
Cattle
EIR BOVIBIOME
Formula complete · lab-tested · field trials nextRumen-protected butyrate delivery for intestinal function and microbial balance.
How it works
A homogeneous lipid-matrix prill combines three butyrate carriers with monolaurin. It is designed to limit rumen release and respond to bile and lipase in the small intestine.
Evidence and readiness
- Completed
- Formulation complete; laboratory-tested. Quantitative release targets are not presented as verified laboratory outcomes.
- Next milestone
- Confirm target release performance in the technical review and conduct controlled cattle field trials before finalising animal-performance claims.
Release design targets: at least 60% payload retained after 24 hours in rumen conditions, then at least 85% of that retained payload released within six hours under bile/lipase conditions.
These percentages are design targets. The public material does not provide a validated release dataset or completed cattle field-trial results.
Commercial application
Focuses on delivery beyond the rumen. Commercial assessment connects payload delivery, animal response, handling and cost per animal.
The full portfolio roadmap
Commercial roadmap
Product readiness and commercial priorities
All five formulations are complete. The roadmap distinguishes the field-tested crop and litter products from the two laboratory-tested feed additives, and identifies the next commercial or validation milestone.
| Product | Completed work | Next milestone |
|---|---|---|
| EIR Biostimulant | Completed formulation, laboratory studies, successful field trials, stability and emulsification testing. | Planned entry: Thailand, followed by ASEAN; registration, positioning and distribution. |
| EIR PESTOX | Completed formulation, successful pepper aphid trials, stability and emulsification testing. | Registration in selected markets, approved labelling and commercial launch. |
| EIROLITTER | Completed formulation, stability testing, laboratory work and a successful two-house commercial field trial. | Market-specific registration, distributor engagement and marketing. |
| EIR AVIBIOME | Finished feed-flake formulation with a protected delivery design; laboratory-tested. | Controlled animal field trials in laying hens; subsequent market-entry planning. |
| EIR BOVIBIOME | Finished lipid-matrix prill with defined rumen-retention and intestinal-release targets; laboratory-tested. | Controlled animal field trials in cattle; subsequent market-entry planning. |
Completed formulation status and product registration are separate milestones. The current investment focus is registration and marketing, with the feed-additive field trials identified as a separate validation requirement.
The next conversation
From evidence to market entry.
Explore investment, licensing or distribution for a defined product and territory.